641 related articles for article (PubMed ID: 10091162)
1. Hormonal replacement therapy with HCG and HU-FSH in thalassaemic patients affected by hypogonadotropic hypogonadism.
Cisternino M; Manzoni SM; Coslovich E; Autelli M
J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():885-90. PubMed ID: 10091162
[TBL] [Abstract][Full Text] [Related]
2. Seminal anti-Müllerian hormone level is a marker of spermatogenic response during long-term gonadotropin therapy in male hypogonadotropic hypogonadism.
Sinisi AA; Esposito D; Maione L; Quinto MC; Visconti D; De Bellis A; Bellastella A; Conzo G; Bellastella G
Hum Reprod; 2008 May; 23(5):1029-34. PubMed ID: 18343809
[TBL] [Abstract][Full Text] [Related]
3. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.
Liu L; Banks SM; Barnes KM; Sherins RJ
J Clin Endocrinol Metab; 1988 Dec; 67(6):1140-5. PubMed ID: 3142911
[TBL] [Abstract][Full Text] [Related]
4. Male hypogonadotropic hypogonadism: factors influencing response to human chorionic gonadotropin and human menopausal gonadotropin, including prior exogenous androgens.
Ley SB; Leonard JM
J Clin Endocrinol Metab; 1985 Oct; 61(4):746-52. PubMed ID: 3928676
[TBL] [Abstract][Full Text] [Related]
5. Induction of puberty in a patient with hypogonadotropic hypogonadism: effect of sequentially applied hCG and pulsatile GnRH administration.
Klingmüller D; Menger D; Wildt L; Leyendecker G; Krück F; Schweikert HU
Horm Metab Res; 1985 Jul; 17(7):358-61. PubMed ID: 3928472
[TBL] [Abstract][Full Text] [Related]
6. A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human follicle-stimulating hormone and human chorionic gonadotropin.
Warne DW; Decosterd G; Okada H; Yano Y; Koide N; Howles CM
Fertil Steril; 2009 Aug; 92(2):594-604. PubMed ID: 18930225
[TBL] [Abstract][Full Text] [Related]
7. Gonadotropin treatment of hypogonadotropic hypogonadal adolescents.
Bouvattier C; Tauber M; Jouret B; Chaussain JL; Rochiccioli P
J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():339-44. PubMed ID: 10698599
[TBL] [Abstract][Full Text] [Related]
8. Induction of puberty with human chorionic gonadotropin and follicle-stimulating hormone in adolescent males with hypogonadotropic hypogonadism.
Barrio R; de Luis D; Alonso M; Lamas A; Moreno JC
Fertil Steril; 1999 Feb; 71(2):244-8. PubMed ID: 9988392
[TBL] [Abstract][Full Text] [Related]
9. Luteinizing hormone receptor-mediated effects on initiation of spermatogenesis in gonadotropin-deficient (hpg) mice are replicated by testosterone.
Spaliviero JA; Jimenez M; Allan CM; Handelsman DJ
Biol Reprod; 2004 Jan; 70(1):32-8. PubMed ID: 12954730
[TBL] [Abstract][Full Text] [Related]
10. Failure of combined follicle-stimulating hormone-testosterone administration to initiate and/or maintain spermatogenesis in men with hypogonadotropic hypogonadism.
Schaison G; Young J; Pholsena M; Nahoul K; Couzinet B
J Clin Endocrinol Metab; 1993 Dec; 77(6):1545-9. PubMed ID: 8263139
[TBL] [Abstract][Full Text] [Related]
11. Testicular growth and spermatogenesis: new goals for pubertal hormone replacement in boys with hypogonadotropic hypogonadism? -a multicentre prospective study of hCG/rFSH treatment outcomes during adolescence.
Rohayem J; Hauffa BP; Zacharin M; Kliesch S; Zitzmann M;
Clin Endocrinol (Oxf); 2017 Jan; 86(1):75-87. PubMed ID: 27467188
[TBL] [Abstract][Full Text] [Related]
12. [Clinical study of hypogonadotropic hypogonadism].
Fuse H; Kazama T; Terada T; Katayama T
Hinyokika Kiyo; 1990 Nov; 36(11):1301-8. PubMed ID: 2126911
[TBL] [Abstract][Full Text] [Related]
13. [A hormone assay as a therapeutic choice in male sterility].
Avril-Ducarne C; Kuhn JM; Cossec A; Bastit P; Bisson JP; Wolf LM
J Gynecol Obstet Biol Reprod (Paris); 1990; 19(7):881-8. PubMed ID: 2126018
[TBL] [Abstract][Full Text] [Related]
14. Maintenance of spermatogenesis in hypogonadotropic hypogonadal men with human chorionic gonadotropin alone.
Depenbusch M; von Eckardstein S; Simoni M; Nieschlag E
Eur J Endocrinol; 2002 Nov; 147(5):617-24. PubMed ID: 12444893
[TBL] [Abstract][Full Text] [Related]
15. Hypogonadotropic hypogonadism: gonadotropin therapy.
Snyder PJ
Curr Ther Endocrinol Metab; 1994; 5():300-3. PubMed ID: 7704739
[No Abstract] [Full Text] [Related]
16. Feedback inhibition of gonadotropins by testosterone in men with hypogonadotropic hypogonadism: comparison to the intact pituitary-testicular axis in primary hypogonadism.
Shimon I; Lubina A; Gorfine M; Ilany J
J Androl; 2006; 27(3):358-64. PubMed ID: 16474013
[TBL] [Abstract][Full Text] [Related]
17. Chronic human chorionic gonadotropin administration in normal men: evidence that follicle-stimulating hormone is necessary for the maintenance of quantitatively normal spermatogenesis in man.
Matsumoto AM; Karpas AE; Bremner WJ
J Clin Endocrinol Metab; 1986 Jun; 62(6):1184-92. PubMed ID: 3084535
[TBL] [Abstract][Full Text] [Related]
18. Addition of recombinant follicle-stimulating hormone to human chorionic gonadotropin treatment in adolescents and young adults with hypogonadotropic hypogonadism promotes normal testicular growth and may promote early spermatogenesis.
Zacharin M; Sabin MA; Nair VV; Dabadghao P
Fertil Steril; 2012 Oct; 98(4):836-42. PubMed ID: 22763096
[TBL] [Abstract][Full Text] [Related]
19. Optimization of spermatogenesis-regulating hormones in patients with non-obstructive azoospermia and its impact on sperm retrieval: a multicentre study.
Hussein A; Ozgok Y; Ross L; Rao P; Niederberger C
BJU Int; 2013 Mar; 111(3 Pt B):E110-4. PubMed ID: 22958644
[TBL] [Abstract][Full Text] [Related]
20. Hormonal therapy of male hypogonadism.
Matsumoto AM
Endocrinol Metab Clin North Am; 1994 Dec; 23(4):857-75. PubMed ID: 7705324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
